- [ Press Releases ](/news-center/press-releases)
 
 

 

  # DynaMedex™ Mobile App Releases New Features Aimed to Enhance Clinical Decision Support Anytime, Anywhere

 

   ~ New User Experience to Highlight Clinical Content Updates and Provide Enhanced Customization ~ 

 

 

    ![Featured Health Care image](https://assets.ebsco.com/m/74346fad5af330d6/original/ebsco-news-center-press-releases-default-image-healthcare-780.png) 

**IPSWICH, Mass. — February 2, 2023 —** [*DynaMedex*](https://www.dynamedex.com/)™, a clinical decision support solution for clinical care teams that combines [*DynaMed*](https://www.dynamed.com/)® disease evidence from EBSCO Information Services ([EBSCO](/health-care)) and [*Micromedex*](https://www.merative.com/clinical-decision-support)® drug evidence from [*Merative*](https://www.merative.com/)™, releases new features and functionality in the *DynaMedex* mobile app. These enhancements are intended to improve the mobile experience for clinical users, making it easy for clinicians to efficiently provide evidence-based patient care on the go.

The *DynaMedex* mobile app will now showcase the solution’s Alerts feed on the home screen, bringing clinical content updates to the forefront of the user experience. Users can customize their feed, choosing to see all updates or selecting to view only potentially practice-changing updates for the clinical topics of their choice.

EBSCO Vice President of Product Management, Clinical Decisions, Julia Colpitts, says with these updates, users can be confident that they are accessing the latest content updates while using their mobile device. “With the mobile app’s new Alerts feed, clinicians can take advantage of mobile access and remain current on the topics of their choosing while on the go. These mobile app enhancements continue our commitment to improving the user experience for clinicians, making it easy for them to efficiently provide patient care.”

The *DynaMedex* mobile app is free with every subscription and is compatible with iOS and Android devices.

**About DynaMedex™**  
*DynaMedex* is a solution for clinical care teams that combines *DynaMed*® disease evidence from EBSCO Information Services (EBSCO) and *Micromedex*® drug evidence from *Merative*™. Learn more at [dynamedex.com](https://www.dynamedex.com/).

**About EBSCO Information Services**  
EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world. EBSCO’s [Clinical Decisions](http://www.clinicaldecisions.com/) suite of products are designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. For more information, visit the EBSCO website at: [www.ebsco.com](/).

\###

**For more information, please contact:**  
Jessica Holmes  
Communications Director  
978-414-0420  
<jmholmes@ebsco.com>



 

Share this:

- [Facebook](https://www.facebook.com/sharer.php?u=https://about.ebsco.com/markdownify/node/84672)
- [Twitter](<https://twitter.com/intent/tweet?text=DynaMedex%E2%84%A2%20Mobile%20App%20Releases%20New%20Features%20Aimed%20to%20%20Enhance%20Clinical%20Decision%20Support%20Anytime%2C%20Anywhere&url=https://about.ebsco.com/markdownify/node/84672&via=EBSCO News>)
- [LinkedIn](<http://www.linkedin.com/shareArticle?mini=true&url=https://about.ebsco.com/markdownify/node/84672&title=DynaMedex%E2%84%A2%20Mobile%20App%20Releases%20New%20Features%20Aimed%20to%20%20Enhance%20Clinical%20Decision%20Support%20Anytime%2C%20Anywhere&source=EBSCO News>)